Mehmet Agirbasli
Overview
Explore the profile of Mehmet Agirbasli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bulut E, Kutucu D, Ustunova S, Agirbasli M, Dedeakayogullari H, Tarhan C, et al.
Exp Physiol
. 2024 Sep;
109(11):1882-1895.
PMID: 39264256
Hyperglycaemia, hyperlipidaemia, hypertension and obesity are the main risk factors affecting the development and prognosis of ischaemic heart disease, which is still an important cause of death today. In our...
2.
Tanrikulu A, Ozdilek B, Agirbasli M
Med Princ Pract
. 2024 Aug;
33(6):562-568.
PMID: 39134015
Objectives: The aim of the study was to investigate serum plasminogen activator inhibitor-1 (PAI-1) levels of patients with Parkinson's disease (PD) and their relationship with clinical findings and treatment of...
3.
Kasap N, Incealtin O, Celik V, Agirbasli M
J Coll Physicians Surg Pak
. 2024 Apr;
34(4):451-455.
PMID: 38576289
Objective: To investigate high-density lipoprotein cholesterol (HDL-C) levels in children with COVID-19. Study Design: Descriptive study. Place and Duration of the Study: Goztepe Professor Suleyman Yalcin City Hospital, Istanbul, Turkiye,...
4.
Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, et al.
Sci Rep
. 2024 Jan;
14(1):165.
PMID: 38168544
An inhibitor of plasminogen activator inhibitor (PAI)-1, TM5614, inhibited thrombosis, inflammation, and fibrosis in several experimental mouse models. To evaluate the efficacy and safety of TM5614 in human COVID-19 pneumonia,...
5.
6.
Agirbasli M, Korkmaz R, Isman F
Cureus
. 2023 May;
15(4):e37254.
PMID: 37168200
Low-density lipoprotein receptor-related protein-1 (LRP1) is an endocytosis receptor that clears inflammatory proteins from circulation. LRP1 has anti-inflammatory effects that bind pro-inflammatory cytokines or ligands. LRP1 has a soluble form...
7.
Aksoy S, Oz D, Oz M, Agirbasli M
Medicina (Kaunas)
. 2023 Apr;
59(4).
PMID: 37109721
: Coronary slow flow (CSF) is an angiographic phenomenon characterized by the slow progression of an injected contrast agent during diagnostic coronary angiography in the absence of significant stenosis. Although...
8.
9.
Sumerkan M, Kalender E, Korkut S, Simsek E, Keskin K, Gurdal A, et al.
Sisli Etfal Hastan Tıp Bul
. 2022 Oct;
56(3):365-374.
PMID: 36304212
Objectives: Mad-honey intoxication (MHI) often presents with all kinds of bradyarrhythmias. Despite numerous publications focused on clinical findings, we aim to evaluate poor prognostic implications, ischemia likely electrocardiography (ECG) changes,...
10.
Ozdilek B, Agirbasli M
Int J Neurosci
. 2022 Oct;
134(6):620-627.
PMID: 36184975
Low density lipoprotein receptor-related protein-1 (LRP-1) is highly expressed in the central nervous system and plays a role in neurodegenerative disorders. The available data on this subject-matter seem to support...